nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergotamine—ADRA2A—epilepsy syndrome	0.171	0.508	CbGaD
Ergotamine—HTR2A—epilepsy syndrome	0.1	0.298	CbGaD
Ergotamine—ABCB1—epilepsy syndrome	0.0655	0.194	CbGaD
Ergotamine—ABCB1—Levetiracetam—epilepsy syndrome	0.0227	0.0701	CbGbCtD
Ergotamine—ABCB1—Clobazam—epilepsy syndrome	0.0157	0.0486	CbGbCtD
Ergotamine—ABCB1—Lamotrigine—epilepsy syndrome	0.0151	0.0468	CbGbCtD
Ergotamine—CYP1A2—Carbamazepine—epilepsy syndrome	0.0149	0.046	CbGbCtD
Ergotamine—CYP1A2—Primidone—epilepsy syndrome	0.0139	0.043	CbGbCtD
Ergotamine—ABCB1—Carbamazepine—epilepsy syndrome	0.013	0.0403	CbGbCtD
Ergotamine—CYP1A2—Propofol—epilepsy syndrome	0.0125	0.0385	CbGbCtD
Ergotamine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0124	0.0384	CbGbCtD
Ergotamine—CYP1A2—Phenobarbital—epilepsy syndrome	0.0119	0.0368	CbGbCtD
Ergotamine—ABCB1—Phenytoin—epilepsy syndrome	0.0117	0.0361	CbGbCtD
Ergotamine—CYP3A4—Trimethadione—epilepsy syndrome	0.0116	0.0357	CbGbCtD
Ergotamine—CYP3A4—Felbamate—epilepsy syndrome	0.0116	0.0357	CbGbCtD
Ergotamine—CYP1A2—Diazepam—epilepsy syndrome	0.0113	0.0349	CbGbCtD
Ergotamine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0109	0.0336	CbGbCtD
Ergotamine—ABCB1—Phenobarbital—epilepsy syndrome	0.0104	0.0322	CbGbCtD
Ergotamine—ABCB1—Midazolam—epilepsy syndrome	0.0103	0.0317	CbGbCtD
Ergotamine—ABCB1—Diazepam—epilepsy syndrome	0.00988	0.0305	CbGbCtD
Ergotamine—CYP3A4—Clonazepam—epilepsy syndrome	0.00983	0.0304	CbGbCtD
Ergotamine—CYP3A4—Clobazam—epilepsy syndrome	0.00942	0.0291	CbGbCtD
Ergotamine—CYP1A2—Valproic Acid—epilepsy syndrome	0.0089	0.0275	CbGbCtD
Ergotamine—CYP3A4—Rufinamide—epilepsy syndrome	0.00801	0.0247	CbGbCtD
Ergotamine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00781	0.0241	CbGbCtD
Ergotamine—HTR1D—meninx—epilepsy syndrome	0.00766	0.0944	CbGeAlD
Ergotamine—CYP3A4—Primidone—epilepsy syndrome	0.00729	0.0225	CbGbCtD
Ergotamine—CYP3A4—Phenytoin—epilepsy syndrome	0.007	0.0216	CbGbCtD
Ergotamine—CYP3A4—Propofol—epilepsy syndrome	0.00653	0.0202	CbGbCtD
Ergotamine—CYP3A4—Acetazolamide—epilepsy syndrome	0.00624	0.0193	CbGbCtD
Ergotamine—CYP3A4—Phenobarbital—epilepsy syndrome	0.00624	0.0193	CbGbCtD
Ergotamine—CYP3A4—Midazolam—epilepsy syndrome	0.00616	0.019	CbGbCtD
Ergotamine—CYP3A4—Diazepam—epilepsy syndrome	0.00592	0.0183	CbGbCtD
Ergotamine—CYP3A4—Zonisamide—epilepsy syndrome	0.00578	0.0178	CbGbCtD
Ergotamine—CYP3A4—Valproic Acid—epilepsy syndrome	0.00466	0.0144	CbGbCtD
Ergotamine—CYP3A4—Topiramate—epilepsy syndrome	0.00421	0.013	CbGbCtD
Ergotamine—HTR2A—phrenic nerve—epilepsy syndrome	0.00412	0.0507	CbGeAlD
Ergotamine—SLC6A2—locus ceruleus—epilepsy syndrome	0.00306	0.0377	CbGeAlD
Ergotamine—HTR1F—ganglion—epilepsy syndrome	0.00276	0.0339	CbGeAlD
Ergotamine—HTR2A—locus ceruleus—epilepsy syndrome	0.00184	0.0227	CbGeAlD
Ergotamine—HTR1B—telencephalic ventricle—epilepsy syndrome	0.00181	0.0223	CbGeAlD
Ergotamine—HTR1D—telencephalic ventricle—epilepsy syndrome	0.00176	0.0216	CbGeAlD
Ergotamine—HTR2C—telencephalic ventricle—epilepsy syndrome	0.00174	0.0214	CbGeAlD
Ergotamine—SLC6A2—autonomic nervous system—epilepsy syndrome	0.00163	0.02	CbGeAlD
Ergotamine—HTR2A—cerebellar cortex—epilepsy syndrome	0.0015	0.0185	CbGeAlD
Ergotamine—HTR1A—telencephalic ventricle—epilepsy syndrome	0.00146	0.018	CbGeAlD
Ergotamine—HTR2A—vagus nerve—epilepsy syndrome	0.00141	0.0173	CbGeAlD
Ergotamine—Sensory loss—Acetazolamide—epilepsy syndrome	0.00134	0.0112	CcSEcCtD
Ergotamine—DRD2—telencephalic ventricle—epilepsy syndrome	0.00132	0.0163	CbGeAlD
Ergotamine—Cyanosis—Phenytoin—epilepsy syndrome	0.00123	0.0104	CcSEcCtD
Ergotamine—Peripheral coldness—Pregabalin—epilepsy syndrome	0.00121	0.0102	CcSEcCtD
Ergotamine—Cyanosis—Carbamazepine—epilepsy syndrome	0.00118	0.00989	CcSEcCtD
Ergotamine—Numbness—Diazepam—epilepsy syndrome	0.00116	0.00976	CcSEcCtD
Ergotamine—HTR1F—forebrain—epilepsy syndrome	0.00116	0.0142	CbGeAlD
Ergotamine—HTR1B—ganglion—epilepsy syndrome	0.00113	0.0139	CbGeAlD
Ergotamine—Sensory loss—Vigabatrin—epilepsy syndrome	0.00113	0.00948	CcSEcCtD
Ergotamine—Sensory loss—Diazepam—epilepsy syndrome	0.00111	0.00934	CcSEcCtD
Ergotamine—HTR1D—ganglion—epilepsy syndrome	0.00109	0.0135	CbGeAlD
Ergotamine—HTR2C—ganglion—epilepsy syndrome	0.00108	0.0133	CbGeAlD
Ergotamine—HTR1F—telencephalon—epilepsy syndrome	0.00106	0.0131	CbGeAlD
Ergotamine—HTR2A—pons—epilepsy syndrome	0.00106	0.0131	CbGeAlD
Ergotamine—HTR1E—brainstem—epilepsy syndrome	0.00104	0.0128	CbGeAlD
Ergotamine—HTR1E—forebrain—epilepsy syndrome	0.001	0.0123	CbGeAlD
Ergotamine—Bradycardia—Amobarbital—epilepsy syndrome	0.000989	0.00831	CcSEcCtD
Ergotamine—HTR2A—autonomic nervous system—epilepsy syndrome	0.000978	0.012	CbGeAlD
Ergotamine—Peripheral coldness—Topiramate—epilepsy syndrome	0.000937	0.00788	CcSEcCtD
Ergotamine—HTR1E—telencephalon—epilepsy syndrome	0.000921	0.0113	CbGeAlD
Ergotamine—HTR1A—ganglion—epilepsy syndrome	0.000911	0.0112	CbGeAlD
Ergotamine—SLC6A2—ganglion—epilepsy syndrome	0.000903	0.0111	CbGeAlD
Ergotamine—HTR2A—telencephalic ventricle—epilepsy syndrome	0.000872	0.0107	CbGeAlD
Ergotamine—DRD2—ganglion—epilepsy syndrome	0.000823	0.0101	CbGeAlD
Ergotamine—Cyanosis—Pregabalin—epilepsy syndrome	0.000817	0.00687	CcSEcCtD
Ergotamine—Bradycardia—Phenobarbital—epilepsy syndrome	0.000742	0.00624	CcSEcCtD
Ergotamine—Vertigo—Primidone—epilepsy syndrome	0.000732	0.00615	CcSEcCtD
Ergotamine—HTR1A—hindbrain—epilepsy syndrome	0.000691	0.00851	CbGeAlD
Ergotamine—Bradycardia—Lacosamide—epilepsy syndrome	0.000684	0.00575	CcSEcCtD
Ergotamine—Hypoaesthesia—Lacosamide—epilepsy syndrome	0.000668	0.00562	CcSEcCtD
Ergotamine—HTR1F—head—epilepsy syndrome	0.000662	0.00815	CbGeAlD
Ergotamine—Vertigo—Trimethadione—epilepsy syndrome	0.000644	0.00541	CcSEcCtD
Ergotamine—ADRA1A—hindbrain—epilepsy syndrome	0.000637	0.00785	CbGeAlD
Ergotamine—HTR1F—nervous system—epilepsy syndrome	0.000628	0.00773	CbGeAlD
Ergotamine—DRD2—hindbrain—epilepsy syndrome	0.000624	0.00769	CbGeAlD
Ergotamine—ADRA1D—forebrain—epilepsy syndrome	0.000613	0.00756	CbGeAlD
Ergotamine—Musculoskeletal discomfort—Primidone—epilepsy syndrome	0.000606	0.00509	CcSEcCtD
Ergotamine—HTR1F—central nervous system—epilepsy syndrome	0.000604	0.00744	CbGeAlD
Ergotamine—Hypoaesthesia—Acetazolamide—epilepsy syndrome	0.000578	0.00486	CcSEcCtD
Ergotamine—HTR1E—head—epilepsy syndrome	0.000573	0.00706	CbGeAlD
Ergotamine—Vertigo—Phenobarbital—epilepsy syndrome	0.00057	0.00479	CcSEcCtD
Ergotamine—ADRA1D—telencephalon—epilepsy syndrome	0.000564	0.00695	CbGeAlD
Ergotamine—Vertigo—Rufinamide—epilepsy syndrome	0.00056	0.0047	CcSEcCtD
Ergotamine—Bradycardia—Propofol—epilepsy syndrome	0.00055	0.00462	CcSEcCtD
Ergotamine—Dihydroergotamine—ADRA2A—epilepsy syndrome	0.000546	0.165	CrCbGaD
Ergotamine—HTR1E—nervous system—epilepsy syndrome	0.000544	0.0067	CbGeAlD
Ergotamine—HTR2A—ganglion—epilepsy syndrome	0.000543	0.00669	CbGeAlD
Ergotamine—Myalgia—Phenobarbital—epilepsy syndrome	0.00054	0.00454	CcSEcCtD
Ergotamine—Bradycardia—Midazolam—epilepsy syndrome	0.000538	0.00452	CcSEcCtD
Ergotamine—Vertigo—Lacosamide—epilepsy syndrome	0.000525	0.00442	CcSEcCtD
Ergotamine—Paraesthesia—Trimethadione—epilepsy syndrome	0.000525	0.00441	CcSEcCtD
Ergotamine—HTR1E—central nervous system—epilepsy syndrome	0.000523	0.00645	CbGeAlD
Ergotamine—Sensory loss—Topiramate—epilepsy syndrome	0.000515	0.00433	CcSEcCtD
Ergotamine—Bradycardia—Fosphenytoin—epilepsy syndrome	0.000512	0.00431	CcSEcCtD
Ergotamine—Hypoaesthesia—Fosphenytoin—epilepsy syndrome	0.000501	0.00421	CcSEcCtD
Ergotamine—Bradycardia—Diazepam—epilepsy syndrome	0.000492	0.00413	CcSEcCtD
Ergotamine—HTR1B—brainstem—epilepsy syndrome	0.000491	0.00604	CbGeAlD
Ergotamine—Hypoaesthesia—Vigabatrin—epilepsy syndrome	0.000488	0.0041	CcSEcCtD
Ergotamine—Myalgia—Clobazam—epilepsy syndrome	0.000483	0.00406	CcSEcCtD
Ergotamine—Hypoaesthesia—Diazepam—epilepsy syndrome	0.000481	0.00404	CcSEcCtD
Ergotamine—HTR1F—brain—epilepsy syndrome	0.00048	0.00591	CbGeAlD
Ergotamine—Asthenia—Primidone—epilepsy syndrome	0.000477	0.00401	CcSEcCtD
Ergotamine—Bradycardia—Felbamate—epilepsy syndrome	0.000476	0.004	CcSEcCtD
Ergotamine—HTR1D—brainstem—epilepsy syndrome	0.000475	0.00585	CbGeAlD
Ergotamine—HTR1B—forebrain—epilepsy syndrome	0.000474	0.00583	CbGeAlD
Ergotamine—Musculoskeletal discomfort—Phenobarbital—epilepsy syndrome	0.000472	0.00397	CcSEcCtD
Ergotamine—HTR2C—brainstem—epilepsy syndrome	0.000471	0.0058	CbGeAlD
Ergotamine—Bradycardia—Zonisamide—epilepsy syndrome	0.000466	0.00392	CcSEcCtD
Ergotamine—HTR1D—forebrain—epilepsy syndrome	0.000459	0.00565	CbGeAlD
Ergotamine—HTR2C—forebrain—epilepsy syndrome	0.000454	0.00559	CbGeAlD
Ergotamine—Bradycardia—Phenytoin—epilepsy syndrome	0.000446	0.00375	CcSEcCtD
Ergotamine—Bradycardia—Oxcarbazepine—epilepsy syndrome	0.000444	0.00373	CcSEcCtD
Ergotamine—Pain—Phenobarbital—epilepsy syndrome	0.000443	0.00372	CcSEcCtD
Ergotamine—Hypoaesthesia—Clonazepam—epilepsy syndrome	0.000439	0.00369	CcSEcCtD
Ergotamine—Vomiting—Amobarbital—epilepsy syndrome	0.000439	0.00369	CcSEcCtD
Ergotamine—Hypoaesthesia—Phenytoin—epilepsy syndrome	0.000436	0.00366	CcSEcCtD
Ergotamine—HTR1B—telencephalon—epilepsy syndrome	0.000436	0.00536	CbGeAlD
Ergotamine—Hypoaesthesia—Oxcarbazepine—epilepsy syndrome	0.000434	0.00365	CcSEcCtD
Ergotamine—Paraesthesia—Lacosamide—epilepsy syndrome	0.000429	0.0036	CcSEcCtD
Ergotamine—HTR2B—forebrain—epilepsy syndrome	0.000427	0.00525	CbGeAlD
Ergotamine—Bradycardia—Carbamazepine—epilepsy syndrome	0.000426	0.00358	CcSEcCtD
Ergotamine—Methysergide—HTR7—epilepsy syndrome	0.000425	0.128	CrCbGaD
Ergotamine—Vomiting—Primidone—epilepsy syndrome	0.000423	0.00355	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Clobazam—epilepsy syndrome	0.000422	0.00355	CcSEcCtD
Ergotamine—HTR1D—telencephalon—epilepsy syndrome	0.000422	0.00519	CbGeAlD
Ergotamine—Asthenia—Trimethadione—epilepsy syndrome	0.00042	0.00353	CcSEcCtD
Ergotamine—HTR2C—telencephalon—epilepsy syndrome	0.000418	0.00514	CbGeAlD
Ergotamine—HTR1E—brain—epilepsy syndrome	0.000416	0.00512	CbGeAlD
Ergotamine—Pruritus—Trimethadione—epilepsy syndrome	0.000414	0.00348	CcSEcCtD
Ergotamine—Vertigo—Midazolam—epilepsy syndrome	0.000413	0.00347	CcSEcCtD
Ergotamine—HTR2A—hindbrain—epilepsy syndrome	0.000412	0.00507	CbGeAlD
Ergotamine—Nausea—Amobarbital—epilepsy syndrome	0.00041	0.00345	CcSEcCtD
Ergotamine—Vertigo—Levetiracetam—epilepsy syndrome	0.000408	0.00343	CcSEcCtD
Ergotamine—Hypertension—Propofol—epilepsy syndrome	0.000406	0.00341	CcSEcCtD
Ergotamine—Hypoaesthesia—Lamotrigine—epilepsy syndrome	0.000402	0.00338	CcSEcCtD
Ergotamine—Myalgia—Propofol—epilepsy syndrome	0.0004	0.00336	CcSEcCtD
Ergotamine—HTR1A—brainstem—epilepsy syndrome	0.000396	0.00488	CbGeAlD
Ergotamine—Nausea—Primidone—epilepsy syndrome	0.000395	0.00332	CcSEcCtD
Ergotamine—Vertigo—Fosphenytoin—epilepsy syndrome	0.000394	0.00331	CcSEcCtD
Ergotamine—SLC6A2—brainstem—epilepsy syndrome	0.000393	0.00484	CbGeAlD
Ergotamine—HTR2B—telencephalon—epilepsy syndrome	0.000392	0.00483	CbGeAlD
Ergotamine—Myalgia—Levetiracetam—epilepsy syndrome	0.000387	0.00325	CcSEcCtD
Ergotamine—Vertigo—Vigabatrin—epilepsy syndrome	0.000384	0.00323	CcSEcCtD
Ergotamine—HTR1A—forebrain—epilepsy syndrome	0.000382	0.00471	CbGeAlD
Ergotamine—SLC6A2—forebrain—epilepsy syndrome	0.000379	0.00467	CbGeAlD
Ergotamine—Hypertension—Fosphenytoin—epilepsy syndrome	0.000378	0.00318	CcSEcCtD
Ergotamine—Vertigo—Diazepam—epilepsy syndrome	0.000378	0.00318	CcSEcCtD
Ergotamine—Tachycardia—Propofol—epilepsy syndrome	0.000374	0.00315	CcSEcCtD
Ergotamine—Myalgia—Fosphenytoin—epilepsy syndrome	0.000373	0.00314	CcSEcCtD
Ergotamine—Vomiting—Trimethadione—epilepsy syndrome	0.000372	0.00313	CcSEcCtD
Ergotamine—Paraesthesia—Acetazolamide—epilepsy syndrome	0.000371	0.00312	CcSEcCtD
Ergotamine—Tachycardia—Midazolam—epilepsy syndrome	0.000366	0.00308	CcSEcCtD
Ergotamine—ADRA1A—brainstem—epilepsy syndrome	0.000365	0.0045	CbGeAlD
Ergotamine—Asthenia—Rufinamide—epilepsy syndrome	0.000365	0.00307	CcSEcCtD
Ergotamine—Myalgia—Vigabatrin—epilepsy syndrome	0.000364	0.00306	CcSEcCtD
Ergotamine—Pruritus—Rufinamide—epilepsy syndrome	0.00036	0.00302	CcSEcCtD
Ergotamine—ADRA1B—head—epilepsy syndrome	0.000359	0.00442	CbGeAlD
Ergotamine—Myalgia—Diazepam—epilepsy syndrome	0.000358	0.00301	CcSEcCtD
Ergotamine—Vertigo—Zonisamide—epilepsy syndrome	0.000358	0.00301	CcSEcCtD
Ergotamine—DRD2—brainstem—epilepsy syndrome	0.000358	0.00441	CbGeAlD
Ergotamine—ADRA1A—forebrain—epilepsy syndrome	0.000352	0.00434	CbGeAlD
Ergotamine—HTR1A—telencephalon—epilepsy syndrome	0.000351	0.00433	CbGeAlD
Ergotamine—Hypertension—Felbamate—epilepsy syndrome	0.000351	0.00295	CcSEcCtD
Ergotamine—ADRA1D—head—epilepsy syndrome	0.000351	0.00433	CbGeAlD
Ergotamine—Musculoskeletal discomfort—Propofol—epilepsy syndrome	0.000349	0.00294	CcSEcCtD
Ergotamine—Tachycardia—Fosphenytoin—epilepsy syndrome	0.000349	0.00293	CcSEcCtD
Ergotamine—SLC6A2—telencephalon—epilepsy syndrome	0.000349	0.00429	CbGeAlD
Ergotamine—Nausea—Trimethadione—epilepsy syndrome	0.000347	0.00292	CcSEcCtD
Ergotamine—Myalgia—Felbamate—epilepsy syndrome	0.000346	0.00291	CcSEcCtD
Ergotamine—DRD2—forebrain—epilepsy syndrome	0.000345	0.00425	CbGeAlD
Ergotamine—Vertigo—Clonazepam—epilepsy syndrome	0.000345	0.0029	CcSEcCtD
Ergotamine—Paraesthesia—Propofol—epilepsy syndrome	0.000344	0.0029	CcSEcCtD
Ergotamine—Hypertension—Zonisamide—epilepsy syndrome	0.000344	0.00289	CcSEcCtD
Ergotamine—Vertigo—Phenytoin—epilepsy syndrome	0.000343	0.00288	CcSEcCtD
Ergotamine—Asthenia—Lacosamide—epilepsy syndrome	0.000342	0.00288	CcSEcCtD
Ergotamine—Vertigo—Oxcarbazepine—epilepsy syndrome	0.000341	0.00287	CcSEcCtD
Ergotamine—ADRA1B—nervous system—epilepsy syndrome	0.00034	0.00419	CbGeAlD
Ergotamine—Myalgia—Zonisamide—epilepsy syndrome	0.000339	0.00285	CcSEcCtD
Ergotamine—Pruritus—Lacosamide—epilepsy syndrome	0.000338	0.00284	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Levetiracetam—epilepsy syndrome	0.000338	0.00284	CcSEcCtD
Ergotamine—Paraesthesia—Midazolam—epilepsy syndrome	0.000337	0.00283	CcSEcCtD
Ergotamine—Tachycardia—Diazepam—epilepsy syndrome	0.000335	0.00282	CcSEcCtD
Ergotamine—ADRA1D—nervous system—epilepsy syndrome	0.000333	0.0041	CbGeAlD
Ergotamine—Paraesthesia—Levetiracetam—epilepsy syndrome	0.000333	0.0028	CcSEcCtD
Ergotamine—Asthenia—Clobazam—epilepsy syndrome	0.000332	0.00279	CcSEcCtD
Ergotamine—Vomiting—Phenobarbital—epilepsy syndrome	0.000329	0.00277	CcSEcCtD
Ergotamine—Hypertension—Phenytoin—epilepsy syndrome	0.000329	0.00277	CcSEcCtD
Ergotamine—HTR2C—medulla oblongata—epilepsy syndrome	0.000328	0.00404	CbGeAlD
Ergotamine—Pain—Propofol—epilepsy syndrome	0.000328	0.00276	CcSEcCtD
Ergotamine—ADRA1B—central nervous system—epilepsy syndrome	0.000328	0.00404	CbGeAlD
Ergotamine—Pruritus—Clobazam—epilepsy syndrome	0.000328	0.00276	CcSEcCtD
Ergotamine—Hypertension—Oxcarbazepine—epilepsy syndrome	0.000328	0.00275	CcSEcCtD
Ergotamine—Vertigo—Carbamazepine—epilepsy syndrome	0.000327	0.00275	CcSEcCtD
Ergotamine—Bradycardia—Valproic Acid—epilepsy syndrome	0.000327	0.00275	CcSEcCtD
Ergotamine—Myalgia—Clonazepam—epilepsy syndrome	0.000327	0.00275	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Fosphenytoin—epilepsy syndrome	0.000326	0.00274	CcSEcCtD
Ergotamine—Myalgia—Phenytoin—epilepsy syndrome	0.000325	0.00273	CcSEcCtD
Ergotamine—Tachycardia—Felbamate—epilepsy syndrome	0.000324	0.00273	CcSEcCtD
Ergotamine—ADRA1A—telencephalon—epilepsy syndrome	0.000324	0.00399	CbGeAlD
Ergotamine—Vomiting—Rufinamide—epilepsy syndrome	0.000323	0.00272	CcSEcCtD
Ergotamine—Myalgia—Oxcarbazepine—epilepsy syndrome	0.000323	0.00272	CcSEcCtD
Ergotamine—Paraesthesia—Fosphenytoin—epilepsy syndrome	0.000321	0.0027	CcSEcCtD
Ergotamine—Pain—Midazolam—epilepsy syndrome	0.000321	0.0027	CcSEcCtD
Ergotamine—ADRA1D—central nervous system—epilepsy syndrome	0.000321	0.00395	CbGeAlD
Ergotamine—Hypoaesthesia—Valproic Acid—epilepsy syndrome	0.00032	0.00269	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Vigabatrin—epilepsy syndrome	0.000318	0.00267	CcSEcCtD
Ergotamine—DRD2—telencephalon—epilepsy syndrome	0.000318	0.00391	CbGeAlD
Ergotamine—Tachycardia—Zonisamide—epilepsy syndrome	0.000317	0.00267	CcSEcCtD
Ergotamine—Pain—Levetiracetam—epilepsy syndrome	0.000317	0.00266	CcSEcCtD
Ergotamine—Bromocriptine—HTR7—epilepsy syndrome	0.000316	0.0955	CrCbGaD
Ergotamine—Vertigo—Lamotrigine—epilepsy syndrome	0.000316	0.00266	CcSEcCtD
Ergotamine—Hypertension—Carbamazepine—epilepsy syndrome	0.000314	0.00264	CcSEcCtD
Ergotamine—Paraesthesia—Vigabatrin—epilepsy syndrome	0.000313	0.00263	CcSEcCtD
Ergotamine—HTR1B—midbrain—epilepsy syndrome	0.000313	0.00385	CbGeAlD
Ergotamine—Musculoskeletal discomfort—Diazepam—epilepsy syndrome	0.000313	0.00263	CcSEcCtD
Ergotamine—Myalgia—Carbamazepine—epilepsy syndrome	0.00031	0.00261	CcSEcCtD
Ergotamine—Paraesthesia—Diazepam—epilepsy syndrome	0.000308	0.00259	CcSEcCtD
Ergotamine—Nausea—Phenobarbital—epilepsy syndrome	0.000308	0.00259	CcSEcCtD
Ergotamine—Tachycardia—Clonazepam—epilepsy syndrome	0.000306	0.00257	CcSEcCtD
Ergotamine—HTR1B—spinal cord—epilepsy syndrome	0.000305	0.00376	CbGeAlD
Ergotamine—Tachycardia—Phenytoin—epilepsy syndrome	0.000304	0.00255	CcSEcCtD
Ergotamine—Hypertension—Lamotrigine—epilepsy syndrome	0.000304	0.00255	CcSEcCtD
Ergotamine—Vomiting—Lacosamide—epilepsy syndrome	0.000303	0.00255	CcSEcCtD
Ergotamine—HTR1D—midbrain—epilepsy syndrome	0.000303	0.00373	CbGeAlD
Ergotamine—Musculoskeletal discomfort—Felbamate—epilepsy syndrome	0.000303	0.00254	CcSEcCtD
Ergotamine—Tachycardia—Oxcarbazepine—epilepsy syndrome	0.000302	0.00254	CcSEcCtD
Ergotamine—Nausea—Rufinamide—epilepsy syndrome	0.000302	0.00254	CcSEcCtD
Ergotamine—HTR2C—midbrain—epilepsy syndrome	0.0003	0.00369	CbGeAlD
Ergotamine—Myalgia—Lamotrigine—epilepsy syndrome	0.0003	0.00252	CcSEcCtD
Ergotamine—Paraesthesia—Felbamate—epilepsy syndrome	0.000298	0.00251	CcSEcCtD
Ergotamine—Pain—Vigabatrin—epilepsy syndrome	0.000298	0.00251	CcSEcCtD
Ergotamine—Asthenia—Acetazolamide—epilepsy syndrome	0.000296	0.00249	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Zonisamide—epilepsy syndrome	0.000296	0.00249	CcSEcCtD
Ergotamine—Bradycardia—Pregabalin—epilepsy syndrome	0.000296	0.00248	CcSEcCtD
Ergotamine—Vomiting—Clobazam—epilepsy syndrome	0.000295	0.00248	CcSEcCtD
Ergotamine—Pain—Diazepam—epilepsy syndrome	0.000293	0.00247	CcSEcCtD
Ergotamine—Lisuride—ADRA2A—epilepsy syndrome	0.000293	0.0884	CrCbGaD
Ergotamine—HTR2C—spinal cord—epilepsy syndrome	0.000293	0.0036	CbGeAlD
Ergotamine—Paraesthesia—Zonisamide—epilepsy syndrome	0.000292	0.00245	CcSEcCtD
Ergotamine—Tachycardia—Carbamazepine—epilepsy syndrome	0.00029	0.00244	CcSEcCtD
Ergotamine—Hypoaesthesia—Pregabalin—epilepsy syndrome	0.000289	0.00243	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Clonazepam—epilepsy syndrome	0.000285	0.0024	CcSEcCtD
Ergotamine—Pain—Felbamate—epilepsy syndrome	0.000284	0.00239	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Phenytoin—epilepsy syndrome	0.000284	0.00238	CcSEcCtD
Ergotamine—Nausea—Lacosamide—epilepsy syndrome	0.000284	0.00238	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Oxcarbazepine—epilepsy syndrome	0.000282	0.00237	CcSEcCtD
Ergotamine—Tachycardia—Lamotrigine—epilepsy syndrome	0.00028	0.00236	CcSEcCtD
Ergotamine—Paraesthesia—Phenytoin—epilepsy syndrome	0.000279	0.00235	CcSEcCtD
Ergotamine—Nausea—Clobazam—epilepsy syndrome	0.000275	0.00231	CcSEcCtD
Ergotamine—Asthenia—Propofol—epilepsy syndrome	0.000275	0.00231	CcSEcCtD
Ergotamine—SLC6A2—medulla oblongata—epilepsy syndrome	0.000274	0.00337	CbGeAlD
Ergotamine—Pruritus—Propofol—epilepsy syndrome	0.000271	0.00228	CcSEcCtD
Ergotamine—HTR1B—head—epilepsy syndrome	0.000271	0.00334	CbGeAlD
Ergotamine—Bromocriptine—ADRA2A—epilepsy syndrome	0.000271	0.0819	CrCbGaD
Ergotamine—Bradycardia—Gabapentin—epilepsy syndrome	0.000271	0.00228	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Carbamazepine—epilepsy syndrome	0.000271	0.00228	CcSEcCtD
Ergotamine—Asthenia—Midazolam—epilepsy syndrome	0.000269	0.00226	CcSEcCtD
Ergotamine—Pain—Clonazepam—epilepsy syndrome	0.000268	0.00225	CcSEcCtD
Ergotamine—ADRA2A—forebrain—epilepsy syndrome	0.000268	0.0033	CbGeAlD
Ergotamine—Paraesthesia—Carbamazepine—epilepsy syndrome	0.000267	0.00224	CcSEcCtD
Ergotamine—Asthenia—Levetiracetam—epilepsy syndrome	0.000266	0.00224	CcSEcCtD
Ergotamine—Pruritus—Midazolam—epilepsy syndrome	0.000265	0.00223	CcSEcCtD
Ergotamine—Hypoaesthesia—Gabapentin—epilepsy syndrome	0.000265	0.00223	CcSEcCtD
Ergotamine—Pain—Oxcarbazepine—epilepsy syndrome	0.000265	0.00223	CcSEcCtD
Ergotamine—HTR1D—head—epilepsy syndrome	0.000263	0.00323	CbGeAlD
Ergotamine—Vomiting—Acetazolamide—epilepsy syndrome	0.000263	0.00221	CcSEcCtD
Ergotamine—Pruritus—Levetiracetam—epilepsy syndrome	0.000262	0.0022	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	0.000262	0.0022	CcSEcCtD
Ergotamine—ADRA1B—brain—epilepsy syndrome	0.00026	0.00321	CbGeAlD
Ergotamine—HTR2C—head—epilepsy syndrome	0.00026	0.0032	CbGeAlD
Ergotamine—Paraesthesia—Lamotrigine—epilepsy syndrome	0.000258	0.00217	CcSEcCtD
Ergotamine—HTR1B—nervous system—epilepsy syndrome	0.000257	0.00317	CbGeAlD
Ergotamine—Asthenia—Fosphenytoin—epilepsy syndrome	0.000257	0.00216	CcSEcCtD
Ergotamine—Methylergometrine—HTR2A—epilepsy syndrome	0.000256	0.0773	CrCbGaD
Ergotamine—ADRA1D—brain—epilepsy syndrome	0.000255	0.00314	CbGeAlD
Ergotamine—Pain—Carbamazepine—epilepsy syndrome	0.000254	0.00214	CcSEcCtD
Ergotamine—Pruritus—Fosphenytoin—epilepsy syndrome	0.000253	0.00213	CcSEcCtD
Ergotamine—HTR1A—midbrain—epilepsy syndrome	0.000252	0.00311	CbGeAlD
Ergotamine—Vertigo—Valproic Acid—epilepsy syndrome	0.000251	0.00211	CcSEcCtD
Ergotamine—Asthenia—Vigabatrin—epilepsy syndrome	0.00025	0.0021	CcSEcCtD
Ergotamine—HTR1D—nervous system—epilepsy syndrome	0.000249	0.00307	CbGeAlD
Ergotamine—HTR1B—central nervous system—epilepsy syndrome	0.000248	0.00305	CbGeAlD
Ergotamine—Pruritus—Vigabatrin—epilepsy syndrome	0.000247	0.00207	CcSEcCtD
Ergotamine—HTR2C—nervous system—epilepsy syndrome	0.000247	0.00304	CbGeAlD
Ergotamine—ADRA2A—telencephalon—epilepsy syndrome	0.000246	0.00303	CbGeAlD
Ergotamine—HTR1A—spinal cord—epilepsy syndrome	0.000246	0.00303	CbGeAlD
Ergotamine—Asthenia—Diazepam—epilepsy syndrome	0.000246	0.00207	CcSEcCtD
Ergotamine—Pain—Lamotrigine—epilepsy syndrome	0.000246	0.00206	CcSEcCtD
Ergotamine—Nausea—Acetazolamide—epilepsy syndrome	0.000245	0.00206	CcSEcCtD
Ergotamine—HTR2B—head—epilepsy syndrome	0.000244	0.00301	CbGeAlD
Ergotamine—Vomiting—Propofol—epilepsy syndrome	0.000244	0.00205	CcSEcCtD
Ergotamine—Pruritus—Diazepam—epilepsy syndrome	0.000243	0.00204	CcSEcCtD
Ergotamine—Hypertension—Valproic Acid—epilepsy syndrome	0.000241	0.00203	CcSEcCtD
Ergotamine—HTR1D—central nervous system—epilepsy syndrome	0.00024	0.00295	CbGeAlD
Ergotamine—Vomiting—Midazolam—epilepsy syndrome	0.000239	0.00201	CcSEcCtD
Ergotamine—Asthenia—Felbamate—epilepsy syndrome	0.000238	0.002	CcSEcCtD
Ergotamine—Myalgia—Valproic Acid—epilepsy syndrome	0.000238	0.002	CcSEcCtD
Ergotamine—HTR2C—central nervous system—epilepsy syndrome	0.000237	0.00292	CbGeAlD
Ergotamine—HTR2A—brainstem—epilepsy syndrome	0.000236	0.00291	CbGeAlD
Ergotamine—Vomiting—Levetiracetam—epilepsy syndrome	0.000236	0.00198	CcSEcCtD
Ergotamine—Pruritus—Felbamate—epilepsy syndrome	0.000235	0.00198	CcSEcCtD
Ergotamine—Asthenia—Zonisamide—epilepsy syndrome	0.000233	0.00196	CcSEcCtD
Ergotamine—HTR2B—nervous system—epilepsy syndrome	0.000232	0.00285	CbGeAlD
Ergotamine—Pruritus—Zonisamide—epilepsy syndrome	0.00023	0.00193	CcSEcCtD
Ergotamine—DRD2—midbrain—epilepsy syndrome	0.000228	0.00281	CbGeAlD
Ergotamine—Bradycardia—Topiramate—epilepsy syndrome	0.000228	0.00192	CcSEcCtD
Ergotamine—Nausea—Propofol—epilepsy syndrome	0.000228	0.00192	CcSEcCtD
Ergotamine—HTR2A—forebrain—epilepsy syndrome	0.000228	0.00281	CbGeAlD
Ergotamine—Vomiting—Fosphenytoin—epilepsy syndrome	0.000227	0.00191	CcSEcCtD
Ergotamine—Vertigo—Pregabalin—epilepsy syndrome	0.000227	0.00191	CcSEcCtD
Ergotamine—Asthenia—Clonazepam—epilepsy syndrome	0.000225	0.00189	CcSEcCtD
Ergotamine—Asthenia—Phenytoin—epilepsy syndrome	0.000223	0.00188	CcSEcCtD
Ergotamine—HTR2B—central nervous system—epilepsy syndrome	0.000223	0.00275	CbGeAlD
Ergotamine—Nausea—Midazolam—epilepsy syndrome	0.000223	0.00187	CcSEcCtD
Ergotamine—Hypoaesthesia—Topiramate—epilepsy syndrome	0.000223	0.00187	CcSEcCtD
Ergotamine—Tachycardia—Valproic Acid—epilepsy syndrome	0.000223	0.00187	CcSEcCtD
Ergotamine—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000222	0.00187	CcSEcCtD
Ergotamine—Pruritus—Clonazepam—epilepsy syndrome	0.000222	0.00186	CcSEcCtD
Ergotamine—Vomiting—Vigabatrin—epilepsy syndrome	0.000222	0.00186	CcSEcCtD
Ergotamine—Pruritus—Phenytoin—epilepsy syndrome	0.00022	0.00185	CcSEcCtD
Ergotamine—Nausea—Levetiracetam—epilepsy syndrome	0.00022	0.00185	CcSEcCtD
Ergotamine—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000219	0.00184	CcSEcCtD
Ergotamine—HTR1A—head—epilepsy syndrome	0.000219	0.0027	CbGeAlD
Ergotamine—Hypertension—Pregabalin—epilepsy syndrome	0.000218	0.00183	CcSEcCtD
Ergotamine—Vomiting—Diazepam—epilepsy syndrome	0.000218	0.00183	CcSEcCtD
Ergotamine—SLC6A2—head—epilepsy syndrome	0.000217	0.00267	CbGeAlD
Ergotamine—Myalgia—Pregabalin—epilepsy syndrome	0.000215	0.00181	CcSEcCtD
Ergotamine—Methysergide—HTR2A—epilepsy syndrome	0.000214	0.0645	CrCbGaD
Ergotamine—Asthenia—Carbamazepine—epilepsy syndrome	0.000213	0.00179	CcSEcCtD
Ergotamine—Nausea—Fosphenytoin—epilepsy syndrome	0.000212	0.00179	CcSEcCtD
Ergotamine—Vomiting—Felbamate—epilepsy syndrome	0.000211	0.00178	CcSEcCtD
Ergotamine—Pruritus—Carbamazepine—epilepsy syndrome	0.00021	0.00177	CcSEcCtD
Ergotamine—HTR2A—telencephalon—epilepsy syndrome	0.000209	0.00258	CbGeAlD
Ergotamine—Dihydroergotamine—ABCB1—epilepsy syndrome	0.000209	0.0631	CrCbGaD
Ergotamine—Vertigo—Gabapentin—epilepsy syndrome	0.000208	0.00175	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000208	0.00175	CcSEcCtD
Ergotamine—HTR1A—nervous system—epilepsy syndrome	0.000208	0.00256	CbGeAlD
Ergotamine—Nausea—Vigabatrin—epilepsy syndrome	0.000207	0.00174	CcSEcCtD
Ergotamine—Vomiting—Zonisamide—epilepsy syndrome	0.000207	0.00174	CcSEcCtD
Ergotamine—Asthenia—Lamotrigine—epilepsy syndrome	0.000206	0.00173	CcSEcCtD
Ergotamine—SLC6A2—nervous system—epilepsy syndrome	0.000206	0.00253	CbGeAlD
Ergotamine—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000205	0.00172	CcSEcCtD
Ergotamine—Nausea—Diazepam—epilepsy syndrome	0.000204	0.00171	CcSEcCtD
Ergotamine—Pruritus—Lamotrigine—epilepsy syndrome	0.000203	0.00171	CcSEcCtD
Ergotamine—ADRA1A—head—epilepsy syndrome	0.000202	0.00248	CbGeAlD
Ergotamine—Tachycardia—Pregabalin—epilepsy syndrome	0.000201	0.00169	CcSEcCtD
Ergotamine—Hypertension—Gabapentin—epilepsy syndrome	0.0002	0.00168	CcSEcCtD
Ergotamine—HTR1A—central nervous system—epilepsy syndrome	0.0002	0.00246	CbGeAlD
Ergotamine—Vomiting—Clonazepam—epilepsy syndrome	0.000199	0.00167	CcSEcCtD
Ergotamine—SLC6A2—central nervous system—epilepsy syndrome	0.000198	0.00244	CbGeAlD
Ergotamine—Vomiting—Phenytoin—epilepsy syndrome	0.000198	0.00166	CcSEcCtD
Ergotamine—DRD2—head—epilepsy syndrome	0.000198	0.00244	CbGeAlD
Ergotamine—Myalgia—Gabapentin—epilepsy syndrome	0.000197	0.00166	CcSEcCtD
Ergotamine—Nausea—Felbamate—epilepsy syndrome	0.000197	0.00166	CcSEcCtD
Ergotamine—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000197	0.00165	CcSEcCtD
Ergotamine—HTR1B—brain—epilepsy syndrome	0.000197	0.00242	CbGeAlD
Ergotamine—HTR1A—cerebellum—epilepsy syndrome	0.000195	0.00241	CbGeAlD
Ergotamine—Pain—Valproic Acid—epilepsy syndrome	0.000195	0.00164	CcSEcCtD
Ergotamine—ADRA2A—medulla oblongata—epilepsy syndrome	0.000194	0.00238	CbGeAlD
Ergotamine—Nausea—Zonisamide—epilepsy syndrome	0.000193	0.00162	CcSEcCtD
Ergotamine—ADRA1A—nervous system—epilepsy syndrome	0.000191	0.00236	CbGeAlD
Ergotamine—Ergonovine—ABCB1—epilepsy syndrome	0.000191	0.0577	CrCbGaD
Ergotamine—HTR1D—brain—epilepsy syndrome	0.00019	0.00234	CbGeAlD
Ergotamine—Vomiting—Carbamazepine—epilepsy syndrome	0.000189	0.00159	CcSEcCtD
Ergotamine—HTR2C—brain—epilepsy syndrome	0.000188	0.00232	CbGeAlD
Ergotamine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000188	0.00158	CcSEcCtD
Ergotamine—DRD2—nervous system—epilepsy syndrome	0.000187	0.00231	CbGeAlD
Ergotamine—Nausea—Clonazepam—epilepsy syndrome	0.000186	0.00156	CcSEcCtD
Ergotamine—Paraesthesia—Pregabalin—epilepsy syndrome	0.000185	0.00156	CcSEcCtD
Ergotamine—Nausea—Phenytoin—epilepsy syndrome	0.000185	0.00155	CcSEcCtD
Ergotamine—Tachycardia—Gabapentin—epilepsy syndrome	0.000185	0.00155	CcSEcCtD
Ergotamine—ADRA1A—central nervous system—epilepsy syndrome	0.000184	0.00227	CbGeAlD
Ergotamine—Nausea—Oxcarbazepine—epilepsy syndrome	0.000184	0.00155	CcSEcCtD
Ergotamine—Vomiting—Lamotrigine—epilepsy syndrome	0.000183	0.00153	CcSEcCtD
Ergotamine—DRD2—central nervous system—epilepsy syndrome	0.000181	0.00222	CbGeAlD
Ergotamine—ADRA1A—cerebellum—epilepsy syndrome	0.00018	0.00222	CbGeAlD
Ergotamine—HTR2B—brain—epilepsy syndrome	0.000177	0.00218	CbGeAlD
Ergotamine—ADRA2A—midbrain—epilepsy syndrome	0.000177	0.00218	CbGeAlD
Ergotamine—Nausea—Carbamazepine—epilepsy syndrome	0.000176	0.00148	CcSEcCtD
Ergotamine—DRD2—cerebellum—epilepsy syndrome	0.000176	0.00217	CbGeAlD
Ergotamine—Pain—Pregabalin—epilepsy syndrome	0.000176	0.00148	CcSEcCtD
Ergotamine—Vertigo—Topiramate—epilepsy syndrome	0.000175	0.00147	CcSEcCtD
Ergotamine—ADRA2A—spinal cord—epilepsy syndrome	0.000173	0.00213	CbGeAlD
Ergotamine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000172	0.00145	CcSEcCtD
Ergotamine—Lisuride—HTR2A—epilepsy syndrome	0.000172	0.0518	CrCbGaD
Ergotamine—Nausea—Lamotrigine—epilepsy syndrome	0.000171	0.00143	CcSEcCtD
Ergotamine—Paraesthesia—Gabapentin—epilepsy syndrome	0.00017	0.00143	CcSEcCtD
Ergotamine—Hypertension—Topiramate—epilepsy syndrome	0.000168	0.00142	CcSEcCtD
Ergotamine—Myalgia—Topiramate—epilepsy syndrome	0.000166	0.0014	CcSEcCtD
Ergotamine—HTR2A—medulla oblongata—epilepsy syndrome	0.000165	0.00203	CbGeAlD
Ergotamine—Asthenia—Valproic Acid—epilepsy syndrome	0.000164	0.00138	CcSEcCtD
Ergotamine—Pain—Gabapentin—epilepsy syndrome	0.000162	0.00136	CcSEcCtD
Ergotamine—Pruritus—Valproic Acid—epilepsy syndrome	0.000161	0.00136	CcSEcCtD
Ergotamine—Bromocriptine—HTR2A—epilepsy syndrome	0.000159	0.048	CrCbGaD
Ergotamine—HTR1A—brain—epilepsy syndrome	0.000159	0.00195	CbGeAlD
Ergotamine—SLC6A2—brain—epilepsy syndrome	0.000157	0.00194	CbGeAlD
Ergotamine—Lisuride—CYP2D6—epilepsy syndrome	0.000157	0.0474	CrCbGaD
Ergotamine—Tachycardia—Topiramate—epilepsy syndrome	0.000155	0.00131	CcSEcCtD
Ergotamine—ADRA2A—head—epilepsy syndrome	0.000153	0.00189	CbGeAlD
Ergotamine—HTR2A—midbrain—epilepsy syndrome	0.00015	0.00185	CbGeAlD
Ergotamine—ABCB1—forebrain—epilepsy syndrome	0.000149	0.00184	CbGeAlD
Ergotamine—Asthenia—Pregabalin—epilepsy syndrome	0.000148	0.00124	CcSEcCtD
Ergotamine—HTR2A—spinal cord—epilepsy syndrome	0.000147	0.00181	CbGeAlD
Ergotamine—ADRA1A—brain—epilepsy syndrome	0.000146	0.0018	CbGeAlD
Ergotamine—Pruritus—Pregabalin—epilepsy syndrome	0.000146	0.00123	CcSEcCtD
Ergotamine—ADRA2A—nervous system—epilepsy syndrome	0.000145	0.00179	CbGeAlD
Ergotamine—Vomiting—Valproic Acid—epilepsy syndrome	0.000145	0.00122	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	0.000145	0.00122	CcSEcCtD
Ergotamine—DRD2—brain—epilepsy syndrome	0.000143	0.00177	CbGeAlD
Ergotamine—Paraesthesia—Topiramate—epilepsy syndrome	0.000143	0.0012	CcSEcCtD
Ergotamine—ADRA2A—central nervous system—epilepsy syndrome	0.00014	0.00172	CbGeAlD
Ergotamine—ABCB1—telencephalon—epilepsy syndrome	0.000137	0.00169	CbGeAlD
Ergotamine—ADRA2A—cerebellum—epilepsy syndrome	0.000137	0.00169	CbGeAlD
Ergotamine—Pain—Topiramate—epilepsy syndrome	0.000136	0.00114	CcSEcCtD
Ergotamine—Asthenia—Gabapentin—epilepsy syndrome	0.000136	0.00114	CcSEcCtD
Ergotamine—Nausea—Valproic Acid—epilepsy syndrome	0.000136	0.00114	CcSEcCtD
Ergotamine—Pruritus—Gabapentin—epilepsy syndrome	0.000134	0.00113	CcSEcCtD
Ergotamine—Vomiting—Pregabalin—epilepsy syndrome	0.000131	0.0011	CcSEcCtD
Ergotamine—HTR2A—head—epilepsy syndrome	0.00013	0.00161	CbGeAlD
Ergotamine—HTR2A—nervous system—epilepsy syndrome	0.000124	0.00152	CbGeAlD
Ergotamine—Nausea—Pregabalin—epilepsy syndrome	0.000123	0.00103	CcSEcCtD
Ergotamine—Vomiting—Gabapentin—epilepsy syndrome	0.00012	0.00101	CcSEcCtD
Ergotamine—HTR2A—central nervous system—epilepsy syndrome	0.000119	0.00147	CbGeAlD
Ergotamine—HTR2A—cerebellum—epilepsy syndrome	0.000116	0.00143	CbGeAlD
Ergotamine—CYP3A4—nervous system—epilepsy syndrome	0.000114	0.00141	CbGeAlD
Ergotamine—Asthenia—Topiramate—epilepsy syndrome	0.000114	0.00096	CcSEcCtD
Ergotamine—Pruritus—Topiramate—epilepsy syndrome	0.000113	0.000947	CcSEcCtD
Ergotamine—Nausea—Gabapentin—epilepsy syndrome	0.000112	0.000945	CcSEcCtD
Ergotamine—ADRA2A—brain—epilepsy syndrome	0.000111	0.00137	CbGeAlD
Ergotamine—CYP3A4—central nervous system—epilepsy syndrome	0.00011	0.00136	CbGeAlD
Ergotamine—ABCB1—medulla oblongata—epilepsy syndrome	0.000108	0.00133	CbGeAlD
Ergotamine—Bromocriptine—ABCB1—epilepsy syndrome	0.000104	0.0314	CrCbGaD
Ergotamine—Vomiting—Topiramate—epilepsy syndrome	0.000101	0.000851	CcSEcCtD
Ergotamine—ABCB1—midbrain—epilepsy syndrome	9.86e-05	0.00121	CbGeAlD
Ergotamine—ABCB1—spinal cord—epilepsy syndrome	9.62e-05	0.00118	CbGeAlD
Ergotamine—Nausea—Topiramate—epilepsy syndrome	9.45e-05	0.000795	CcSEcCtD
Ergotamine—HTR2A—brain—epilepsy syndrome	9.45e-05	0.00116	CbGeAlD
Ergotamine—ABCB1—head—epilepsy syndrome	8.55e-05	0.00105	CbGeAlD
Ergotamine—ABCB1—nervous system—epilepsy syndrome	8.1e-05	0.000998	CbGeAlD
Ergotamine—ABCB1—central nervous system—epilepsy syndrome	7.8e-05	0.000961	CbGeAlD
Ergotamine—ABCB1—cerebellum—epilepsy syndrome	7.63e-05	0.000939	CbGeAlD
Ergotamine—ABCB1—brain—epilepsy syndrome	6.19e-05	0.000763	CbGeAlD
Ergotamine—ADRA1B—Signaling Pathways—AGT—epilepsy syndrome	2.26e-06	1.66e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—YWHAZ—epilepsy syndrome	2.25e-06	1.65e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CCR5—epilepsy syndrome	2.25e-06	1.65e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—CCL2—epilepsy syndrome	2.25e-06	1.65e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—HES1—epilepsy syndrome	2.24e-06	1.64e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—AGT—epilepsy syndrome	2.23e-06	1.64e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—NGF—epilepsy syndrome	2.23e-06	1.64e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—APOE—epilepsy syndrome	2.22e-06	1.63e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CCR5—epilepsy syndrome	2.21e-06	1.63e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—RELA—epilepsy syndrome	2.2e-06	1.62e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—HTR2A—epilepsy syndrome	2.2e-06	1.62e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—PRKCB—epilepsy syndrome	2.2e-06	1.61e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—APOE—epilepsy syndrome	2.19e-06	1.61e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IL6ST—epilepsy syndrome	2.19e-06	1.61e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—PRKCB—epilepsy syndrome	2.19e-06	1.61e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—FGF2—epilepsy syndrome	2.18e-06	1.6e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IL6ST—epilepsy syndrome	2.18e-06	1.6e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—FYN—epilepsy syndrome	2.18e-06	1.6e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—KDR—epilepsy syndrome	2.17e-06	1.6e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—H2AFX—epilepsy syndrome	2.17e-06	1.59e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CCR5—epilepsy syndrome	2.17e-06	1.59e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—MEF2C—epilepsy syndrome	2.16e-06	1.59e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—MTOR—epilepsy syndrome	2.16e-06	1.59e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—RELA—epilepsy syndrome	2.16e-06	1.58e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.13e-06	1.56e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—HTR2A—epilepsy syndrome	2.12e-06	1.56e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	2.12e-06	1.56e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—MTOR—epilepsy syndrome	2.11e-06	1.55e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	2.09e-06	1.54e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—PRKCB—epilepsy syndrome	2.09e-06	1.54e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TSC2—epilepsy syndrome	2.09e-06	1.54e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—AGT—epilepsy syndrome	2.09e-06	1.53e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IL6ST—epilepsy syndrome	2.08e-06	1.53e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—POMC—epilepsy syndrome	2.07e-06	1.52e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—NGF—epilepsy syndrome	2.07e-06	1.52e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TSC2—epilepsy syndrome	2.06e-06	1.51e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—AGT—epilepsy syndrome	2.05e-06	1.51e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—APOE—epilepsy syndrome	2.04e-06	1.5e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—FGF2—epilepsy syndrome	2.03e-06	1.49e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CCL2—epilepsy syndrome	2.03e-06	1.49e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—RELA—epilepsy syndrome	2.03e-06	1.49e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	2.02e-06	1.48e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TSC2—epilepsy syndrome	2.01e-06	1.48e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CCR5—epilepsy syndrome	2.01e-06	1.48e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—APOE—epilepsy syndrome	2.01e-06	1.48e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—AGT—epilepsy syndrome	2.01e-06	1.48e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—BCHE—epilepsy syndrome	2.01e-06	1.48e-05	CbGpPWpGaD
Ergotamine—HTR1D—GPCR downstream signaling—AKT1—epilepsy syndrome	2e-06	1.47e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—KDR—epilepsy syndrome	2e-06	1.47e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	2e-06	1.47e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—POMC—epilepsy syndrome	1.99e-06	1.46e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—MTOR—epilepsy syndrome	1.99e-06	1.46e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—CASP3—epilepsy syndrome	1.99e-06	1.46e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—HMOX1—epilepsy syndrome	1.97e-06	1.45e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—KDR—epilepsy syndrome	1.97e-06	1.45e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—APOE—epilepsy syndrome	1.97e-06	1.45e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	1.97e-06	1.45e-05	CbGpPWpGaD
Ergotamine—HTR1B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.96e-06	1.44e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	1.96e-06	1.44e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—CAT—epilepsy syndrome	1.95e-06	1.43e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CCL2—epilepsy syndrome	1.95e-06	1.43e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—CASP3—epilepsy syndrome	1.94e-06	1.43e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—KDR—epilepsy syndrome	1.93e-06	1.42e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—JUN—epilepsy syndrome	1.93e-06	1.42e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	1.93e-06	1.42e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	1.92e-06	1.41e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	1.92e-06	1.41e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—POMC—epilepsy syndrome	1.91e-06	1.4e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	1.9e-06	1.39e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	1.9e-06	1.39e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	1.89e-06	1.39e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—JUN—epilepsy syndrome	1.89e-06	1.39e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—TH—epilepsy syndrome	1.89e-06	1.39e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—RELA—epilepsy syndrome	1.88e-06	1.39e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—POMC—epilepsy syndrome	1.88e-06	1.38e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—MMP9—epilepsy syndrome	1.88e-06	1.38e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.87e-06	1.38e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	1.87e-06	1.37e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	1.87e-06	1.37e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CCL2—epilepsy syndrome	1.86e-06	1.37e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	1.86e-06	1.37e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.86e-06	1.37e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	1.86e-06	1.37e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	1.85e-06	1.36e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—MTOR—epilepsy syndrome	1.85e-06	1.36e-05	CbGpPWpGaD
Ergotamine—HTR2B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.84e-06	1.36e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—MMP9—epilepsy syndrome	1.84e-06	1.35e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—FGF2—epilepsy syndrome	1.83e-06	1.35e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	1.83e-06	1.35e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—CASP3—epilepsy syndrome	1.83e-06	1.34e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.82e-06	1.34e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—AKT1—epilepsy syndrome	1.82e-06	1.34e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.81e-06	1.33e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	1.79e-06	1.32e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—AKT1—epilepsy syndrome	1.78e-06	1.31e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—JUN—epilepsy syndrome	1.77e-06	1.3e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	1.77e-06	1.3e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.76e-06	1.29e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	1.76e-06	1.29e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—POMC—epilepsy syndrome	1.76e-06	1.29e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—SRC—epilepsy syndrome	1.73e-06	1.27e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	1.73e-06	1.27e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	1.73e-06	1.27e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—MMP9—epilepsy syndrome	1.73e-06	1.27e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	1.72e-06	1.26e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	1.72e-06	1.26e-05	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR downstream signaling—AKT1—epilepsy syndrome	1.72e-06	1.26e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—ALB—epilepsy syndrome	1.71e-06	1.26e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	1.7e-06	1.25e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—CASP3—epilepsy syndrome	1.7e-06	1.25e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—SRC—epilepsy syndrome	1.69e-06	1.25e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	1.69e-06	1.24e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	1.69e-06	1.24e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—VEGFA—epilepsy syndrome	1.69e-06	1.24e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—FGF2—epilepsy syndrome	1.68e-06	1.24e-05	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—AKT1—epilepsy syndrome	1.68e-06	1.24e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—AKT1—epilepsy syndrome	1.67e-06	1.23e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	1.67e-06	1.23e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	1.66e-06	1.22e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—JUN—epilepsy syndrome	1.65e-06	1.21e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—VEGFA—epilepsy syndrome	1.65e-06	1.21e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	1.64e-06	1.21e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.64e-06	1.2e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	1.63e-06	1.2e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	1.61e-06	1.18e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—MMP9—epilepsy syndrome	1.61e-06	1.18e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	1.6e-06	1.18e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—SRC—epilepsy syndrome	1.59e-06	1.17e-05	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—AKT1—epilepsy syndrome	1.59e-06	1.17e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	1.58e-06	1.16e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	1.57e-06	1.16e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—RELA—epilepsy syndrome	1.56e-06	1.15e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—AKT1—epilepsy syndrome	1.56e-06	1.15e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.56e-06	1.14e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—CAT—epilepsy syndrome	1.56e-06	1.14e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	1.55e-06	1.14e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.55e-06	1.14e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—VEGFA—epilepsy syndrome	1.55e-06	1.14e-05	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.55e-06	1.14e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—AGT—epilepsy syndrome	1.54e-06	1.14e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	1.54e-06	1.13e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	1.53e-06	1.13e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—MTOR—epilepsy syndrome	1.53e-06	1.13e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	1.53e-06	1.12e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—APOE—epilepsy syndrome	1.51e-06	1.11e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	1.51e-06	1.11e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	1.5e-06	1.1e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	1.5e-06	1.1e-05	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.5e-06	1.1e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	1.49e-06	1.1e-05	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	1.49e-06	1.09e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	1.48e-06	1.09e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—SRC—epilepsy syndrome	1.48e-06	1.09e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.48e-06	1.09e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	1.47e-06	1.08e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.46e-06	1.08e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—TH—epilepsy syndrome	1.46e-06	1.07e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	1.45e-06	1.07e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—VEGFA—epilepsy syndrome	1.44e-06	1.06e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—RELA—epilepsy syndrome	1.44e-06	1.06e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	1.44e-06	1.06e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	1.43e-06	1.05e-05	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.42e-06	1.05e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	1.42e-06	1.04e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	1.41e-06	1.04e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CASP3—epilepsy syndrome	1.41e-06	1.04e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—GPX1—epilepsy syndrome	1.41e-06	1.03e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	1.41e-06	1.03e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	1.4e-06	1.03e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	1.39e-06	1.02e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	1.39e-06	1.02e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	1.39e-06	1.02e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	1.39e-06	1.02e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—JUN—epilepsy syndrome	1.37e-06	1.01e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	1.36e-06	1e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	1.36e-06	9.98e-06	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	1.35e-06	9.93e-06	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	1.34e-06	9.83e-06	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—MMP9—epilepsy syndrome	1.33e-06	9.8e-06	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.31e-06	9.65e-06	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	1.3e-06	9.57e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	1.3e-06	9.56e-06	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—POMC—epilepsy syndrome	1.3e-06	9.56e-06	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—AKT1—epilepsy syndrome	1.29e-06	9.5e-06	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.29e-06	9.49e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	1.29e-06	9.49e-06	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	1.29e-06	9.49e-06	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	1.28e-06	9.44e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	1.28e-06	9.41e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	1.27e-06	9.3e-06	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.26e-06	9.3e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—JUN—epilepsy syndrome	1.26e-06	9.29e-06	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	1.26e-06	9.24e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	1.25e-06	9.21e-06	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	1.25e-06	9.19e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	1.24e-06	9.14e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—AGT—epilepsy syndrome	1.23e-06	9.07e-06	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—SRC—epilepsy syndrome	1.23e-06	9.03e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	1.23e-06	9.03e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	1.22e-06	8.95e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.22e-06	8.94e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	1.21e-06	8.89e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—APOE—epilepsy syndrome	1.21e-06	8.88e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.2e-06	8.82e-06	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—VEGFA—epilepsy syndrome	1.2e-06	8.8e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	1.19e-06	8.76e-06	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—ALB—epilepsy syndrome	1.19e-06	8.71e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	1.18e-06	8.7e-06	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.18e-06	8.64e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	1.17e-06	8.62e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.17e-06	8.58e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	1.16e-06	8.56e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	1.15e-06	8.44e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—SRC—epilepsy syndrome	1.13e-06	8.33e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	1.13e-06	8.31e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	1.11e-06	8.2e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	1.1e-06	8.11e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	1.1e-06	8.09e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	1.09e-06	8.02e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	1.09e-06	7.98e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.09e-06	7.98e-06	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—AKT1—epilepsy syndrome	1.08e-06	7.9e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	1.07e-06	7.84e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	1.06e-06	7.82e-06	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—AKT1—epilepsy syndrome	1.05e-06	7.74e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—POMC—epilepsy syndrome	1.04e-06	7.63e-06	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.04e-06	7.62e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	1.01e-06	7.46e-06	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—AKT1—epilepsy syndrome	9.89e-07	7.27e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	9.88e-07	7.26e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—AGT—epilepsy syndrome	9.52e-07	7e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—ALB—epilepsy syndrome	9.46e-07	6.96e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—APOE—epilepsy syndrome	9.33e-07	6.85e-06	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—AKT1—epilepsy syndrome	9.2e-07	6.76e-06	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	8.31e-07	6.11e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	8.28e-07	6.09e-06	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	8.02e-07	5.89e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—POMC—epilepsy syndrome	8.01e-07	5.89e-06	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	7.98e-07	5.86e-06	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—AKT1—epilepsy syndrome	7.64e-07	5.61e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—AKT1—epilepsy syndrome	7.54e-07	5.54e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ALB—epilepsy syndrome	7.3e-07	5.37e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	7.04e-07	5.18e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	6.93e-07	5.09e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	6.78e-07	4.99e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	6.39e-07	4.7e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	6.3e-07	4.63e-06	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—AKT1—epilepsy syndrome	5.21e-07	3.83e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—AKT1—epilepsy syndrome	4.16e-07	3.06e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	3.21e-07	2.36e-06	CbGpPWpGaD
